Childrens Acetaminophen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in pediatric patients, with specific caution advised for those concurrently taking the anticoagulant warfarin. Healthcare professionals should ensure that patients or caregivers consult with a doctor or pharmacist prior to administration if the child is on warfarin therapy.

It is essential to adhere to the recommended dosage guidelines to avoid the risk of overdose. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in pediatric patients, and healthcare professionals should refer to the following dosage guidelines. Prior to administration, the product must be shaken well. The appropriate dose should be determined using the dosing chart below, prioritizing weight when possible; otherwise, age may be used as a guide.

Only the enclosed dosing cup, specifically designed for this product, should be utilized for measuring doses. If necessary, doses may be repeated every 4 hours while symptoms persist, but it is imperative not to exceed 5 doses within a 24-hour period.

Dosage Chart:

• For patients weighing under 24 lbs or under 2 years of age: Consult a physician.

• For patients weighing 25 to 35 lbs and aged 2 to 3 years: Administer 1 teaspoon (5 mL).

• For patients weighing 36 to 47 lbs and aged 4 to 5 years: Administer 1 1/2 teaspoons (7.5 mL).

• For patients weighing 48 to 59 lbs and aged 6 to 8 years: Administer 2 teaspoons (10 mL).

• For patients weighing 60 to 71 lbs and aged 9 to 10 years: Administer 2 1/2 teaspoons (12.5 mL).

• For patients weighing 72 to 95 lbs and aged 11 years: Administer 2 1/2 teaspoons (12.5 mL).

Dosage may be adjusted as directed by a healthcare professional.

Contraindications

Use of this product is contraindicated in patients who exceed the recommended dose, as this may lead to overdose. No other specific contraindications have been identified.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen, if the maximum daily dosage of more than 5 doses in 24 hours is exceeded or if it is taken concurrently with other medications containing acetaminophen.

Acetaminophen has been associated with severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

Healthcare professionals should be vigilant regarding sore throat symptoms. If a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a prompt consultation with a physician is advised.

This product should not be used in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in another medication, consultation with a doctor or pharmacist is recommended. Additionally, this product should not be administered to children who are allergic to acetaminophen or any of the inactive ingredients.

Prior to use, it is essential to consult a healthcare provider if the child has a history of liver disease. Furthermore, consultation with a doctor or pharmacist is advised if the child is currently taking the anticoagulant warfarin.

When utilizing this product, it is critical to adhere to the recommended dosage to avoid overdose.

Healthcare professionals should instruct caregivers to discontinue use and seek medical advice if the child experiences worsening pain lasting more than 5 days, fever that worsens or persists for more than 3 days, or the emergence of new symptoms, redness, or swelling, as these may indicate a serious condition.

In the event of an overdose, immediate medical attention is necessary. Caregivers should contact the Poison Control Center at 1-800-222-1222 without delay, as prompt medical intervention is crucial, even if no signs or symptoms are initially apparent.

Side Effects

Severe liver damage may occur in patients who exceed the maximum daily amount of five doses in 24 hours or who take the product in conjunction with other medications containing acetaminophen. Patients should be aware that acetaminophen can cause severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Patients experiencing a severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting should consult a healthcare professional promptly. The product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in another medication, patients are advised to consult a doctor or pharmacist. Additionally, the product is contraindicated in patients with a known allergy to acetaminophen or any of the inactive ingredients.

Before using this product, patients with liver disease should seek medical advice. Furthermore, those taking the anticoagulant warfarin should consult a healthcare provider or pharmacist prior to use. It is crucial for patients to adhere to the recommended dosage and to refrain from exceeding it, as outlined in the overdose warning.

Patients should discontinue use and consult a doctor if pain worsens or persists for more than five days, if fever worsens or lasts for more than three days, or if new symptoms arise, including redness or swelling, as these may indicate a serious condition. In the event of an overdose, immediate medical help should be sought, or the Poison Control Center (1-800-222-1222) should be contacted, as prompt medical attention is essential even in the absence of noticeable signs or symptoms.

Drug Interactions

Acetaminophen has been observed to enhance the anticoagulant effects of warfarin, which may result in an elevated risk of bleeding. It is recommended that the International Normalized Ratio (INR) be monitored closely in patients receiving both acetaminophen and warfarin to ensure safe therapeutic levels and to mitigate the risk of adverse effects.

No additional drug interactions or interactions with laboratory tests have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Acetaminophen (children acetaminophen cherry). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age who weigh less than 24 lbs should be advised to consult a doctor before use. For children aged 2 to 3 years weighing 25 to 35 lbs, the recommended dosage is 1 teaspoon (5 mL). For those aged 4 to 5 years and weighing 36 to 47 lbs, the dosage increases to 1 1/2 teaspoons (7.5 mL). Children aged 6 to 8 years weighing 48 to 59 lbs should receive 2 teaspoons (10 mL), while those aged 9 to 10 years weighing 60 to 71 lbs may take 2 1/2 teaspoons (12.5 mL). For children aged 11 years weighing between 72 to 95 lbs, the dosage remains at 2 1/2 teaspoons (12.5 mL).

Healthcare professionals should be aware of several warnings associated with use in pediatric patients. Severe liver damage may occur if more than 5 doses are taken within a 24-hour period, which is the maximum daily amount. Acetaminophen may also cause severe skin reactions, including symptoms such as skin reddening, blisters, and rash. If a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a doctor should be consulted promptly. It is crucial to avoid using this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. Additionally, a doctor should be consulted before use if the child has liver disease or is taking the blood-thinning medication warfarin.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted. Quick medical attention is critical, even if no signs or symptoms are present. Proper storage is essential; the medication should be kept out of reach of children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions for pregnant patients remain undefined. Healthcare professionals should exercise caution when considering this product for women of childbearing potential and weigh the potential risks against the benefits. It is advisable to discuss any potential implications with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. Severe liver damage may occur if the maximum daily amount of more than 5 doses in 24 hours is exceeded or if the product is taken concurrently with other medications containing acetaminophen.

It is advised that patients with liver disease consult a healthcare professional prior to use. Additionally, patients taking the anticoagulant warfarin should seek guidance from a doctor or pharmacist before using this product, as potential interactions may necessitate monitoring or dosage adjustments.

To minimize the risk of overdose and associated liver damage, patients must adhere strictly to the recommended dosing guidelines.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance by contacting the Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial, even in the absence of noticeable signs or symptoms. Healthcare professionals should be aware that early recognition and management of overdose can significantly impact patient outcomes.

It is essential to monitor the patient closely for any potential symptoms that may arise following an overdose. The specific manifestations can vary depending on the substance involved and the amount ingested. Therefore, a thorough assessment and appropriate management strategies should be implemented as soon as possible to mitigate any adverse effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified cases of severe skin reactions associated with acetaminophen. Reported symptoms include skin reddening, blisters, and rash. These events were documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 1-800-222-1222 in the event of an overdose. It is crucial to obtain prompt medical attention, even if the patient does not exhibit any signs or symptoms of overdose.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any of the following: worsening pain that persists for more than 5 days, a fever that worsens or lasts longer than 3 days, or the emergence of new symptoms, redness, or swelling. These may indicate a serious underlying condition that requires further evaluation.

It is important for healthcare providers to inquire about the patient's medical history, specifically asking if the child has liver disease, as this may affect the safety and efficacy of the treatment. Additionally, patients should be advised to consult with a doctor or pharmacist before using this product if the child is currently taking the blood-thinning medication warfarin. Providers should emphasize the importance of adhering to the recommended dosage to avoid the risk of overdose.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at room temperature, within the range of 20° to 25°C (68° to 77°F). Care must be taken to protect the product from freezing, as well as from exposure to light to maintain its integrity and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Childrens Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)